There is a paucity of data describing acute kidney injury (AKI) following transcatheter aortic valve implantation and its impact on mortality remains unknown. We therefore evaluate the incidence, predictors and impact of AKI following transcatheter aortic valve implantation. We searched MEDLINE for studies from 2008 to 2013, evaluating AKI after transcatheter aortic valve implantation. All studies were compared according to the incidence, predictors and impact of AKI following transcatheter aortic valve implantation. AKI was diagnosed according to the Valve Academic Research Consortium definition using the RIFLE criteria. Thirteen studies with more than 1900 patients were included. AKI occurred in 8.3-57% of the patients. The following factors were associated with AKI: blood transfusion; transapical access; preoperative creatinine concentration; peripheral vascular disease; hypertension; and procedural bleeding events. The 30-day mortality rate in patients with AKI ranged from 13.3% to 44.4% and was 2-6-fold higher than in patients without AKI. The amount of contrast agent used was not associated with the occurrence of AKI. AKI is a common complication, with an incidence of 8.3-57% following transcatheter aortic valve implantation. Patients with AKI had higher 30-day and late mortality rates. However, AKI was related to the amount of contrast volume used in only one study. © 2014 Elsevier Masson SAS. All rights reserved. Les facteurs suivants étaient liés à l'occurrence de L'IRA : la transfusion sanguine ; l'accés transapical ; la créatinine plasmatique ; l'arthropathie oblitérante periphérique ; la tension artérielle ; et l'hémorrhagie intraopérative. L'insuffisance rénale aiguë est une complication fréquente avec une incidence de 8,3 % à 57 % chez les patients ayant une implantation de valves aortiques par voie percutanée. Les patients présentant une IRA ont une haute mortalité dans les premiers 30 jours après l implantation et à long terme. En revanche, la dose du produit de contraste n'est pas un facteur de risque que dans seulement une étude.
Background
Acute kidney injury (AKI) is a common complication in patients undergoing cardiac surgery, occurring in up to 30% of all patients. Moreover, an estimated 2-15% patients require renal replacement therapy (RRT) after a surgical cardiac procedure, with an in-hospital mortality rate of > 40% [1] .
Transcatheter aortic valve implantation (TAVI) has emerged as an alternative therapy in high-risk patients with severe aortic stenosis. Despite the encouraging results associated with TAVI, post-procedural AKI remains a common complication, with a wide range of reported incidences [2] .
Since the introduction of the Valve Academic Research Consortium (VARC) criteria in January 2011 for standardizing definitions of clinical endpoints for TAVI [3] , a recent pooled analysis confirmed the use of VARC criteria in 16 studies involving 3519 patients [4] . The diagnosis of AKI was recommended to be made using the modified RIFLE criteria. The recently published VARC-2 criteria recommended the use of the Acute Kidney Injury Network (AKIN) classification [5] . In comparison with the original VARC criteria, the timing for the diagnosis of AKI is extended from 72 hours to 7 days, to ensure the association with the procedure. Patients with AKI should be followed for 7 days during the index hospitalization.
TAVI procedures involve the administration of contrast agent; the need for rapid pacing with resulting hypotension that may influence renal function and lead to acute kidney injury. Moreover, atherosclerosis is a co-morbidity in the majority of patients undergoing TAVI, with the risk of embolization during the implantation.
Our aim in this review was to analyse the incidence of AKI among patients undergoing TAVI in the literature. In addition, we intended to show and compare all the predictors of AKI and mortality rates in the appropriate studies. Moreover, we tried to assess whether contrast agent has an influence on AKI after TAVI.
Methods
We performed a web-based search on PubMed to find articles describing AKI after TAVI. The following keywords were used: transcatheter aortic, acute kidney injury and VARC. Only articles that described AKI incidence, prognostic factors and mortality in details were evaluated.
Definition of acute kidney injury
AKI was defined according to the RIFLE criteria or the VARC criteria (using the modified RIFLE criteria) ( Table 1) [3] . The decision to undertake RRT during the index hospitalization was made by the intensivist responsible for the patient. Among all the reviewed studies, four used the RIFLE criteria and six used the VARC criteria. Only one study used the AKIN classification [6] . 
Statistical analysis
Continuous variables are presented as means ± standard deviations or medians with interquartile ranges. Categorical variables are presented as frequencies (percentages).
Results and discussion
Our systematic search found 13 studies with more than 1900 patients (aged 79-84 years) who underwent TAVI for severe aortic stenosis between 2006 and 2012 ( Fig. 1) . The EuroSCORE ranged from 18% to 34% and the STS score ranged from 6% to 14% ( Table 2 ). All studies were published between 2010 and 2013. 
Incidence of acute kidney injury after transcatheter aortic valve implantation
According to the evaluated studies, the incidence of AKI after TAVI ranged from 8.3% to 57% (Table 3) . RRT, however, was required in 2-40% of all patients. The incidence of AKI was highest in the studies by Strauch et al. (42%) [7] and Saia et al. (57%) [8] . Of note, in the latter study, 87.3% of all the patients were presented with chronic kidney disease. Interestingly, only 4.9% underwent RRT and the incidence of AKI was two-fold higher in patients undergoing transapical TAVI than in those undergoing transfemoral TAVI. A lower incidence of AKI was observed in the study by Genereux et al. [9] . The authors compared patients in stages 0 and 1 (AKI 0-1) versus patients in stages 2 and 3 (AKI 2-3), according to the VARC criteria. AKI occurred in only 8.3% of the 218 evaluated patients. However, this study population exhibited the highest 30-day and 1-year mortality rates (44.4% and 55.6%, respectively). In their study, Genereux et al. defined AKI stages 2 and 3 as significant AKI, which explains the lower rate of AKI after TAVI. If the authors included patients with stage 1 AKI, the incidence of AKI increased to 34.4%.
RRT as rescue in patients with oliguria and anuria ranged from 0% to 18.6%. The decision to undertake RRT during the index hospitalization was made by the intensivist and could not be compared between studies. Approximately one quarter of patients with AKI underwent RRT. Moreover, patients who had RRT had a worse outcome than AKI patients who did not have RRT. Thus, is RRT a prognostic factor for mortality after AKI? Results from the study by Van Linden et al. showed a nine-fold higher mortality in those who had RRT. Additionally, in the multivariable analysis, serum creatinine > 1.1 (mg/dL), estimated glomerular filtration rate (eGFR) < 60 (mL/min/1.73 m 2 ), blood transfusion > 5 units and leucocyte count > 12 g/L remained as independent predictors of RRT during the index hospitalization [10] .
Predictors of acute kidney injury
Patients, undergoing TAVI, were presented with severe co-morbidities, such as chronic obstructive pulmonary disease, hypertension, diabetes, peripheral vascular disease, porcelain aorta, coronary heart disease, previous cerebrovascular disease and chronic renal failure. Predictors of AKI were baseline creatinine concentration [2, 6, 11] , blood [14] 24 (14.6) 0 Sinning et al. [6] 20 (26.0) 28 (40.0) Saia et al. [8] 42 (41.7) 5 (4.9) Genereux et al. [9] 18 (8.3) 9 (4.1) Nuis et al. [13] 22 (19.0) 2 (2.0) Van Linden et al. [10] 42 (16.1) 42 (15.7) Strauch et al. [7] 16 (57.0) 6 (21.0) Bagur et al. [12] 25 (11.7) 3 (1.4) Aregger et al. [16] 15 (28.0) 4 (7.4) Khawaja et al. [15] 89 (35.9) 4 (10.0) Alassar et al. [11] 9 (12.3) NA Gebauer et al. [25] 30 ( transfusion [12, 13] , transapical approach [8, 14] , peripheral vascular disease [15] , logistic EuroSCORE [13] , diabetes mellitus [11, 15] , and contrast agent [10] (Table 4) . Saia et al. showed that AKI was related to the TAVI access. Patients in whom the transapical access was used exhibited more AKI than those in whom the transfemoral access was used (66.7% vs 30.3%; P = 0.004), even after adjustment for baseline differences [8] . Moreover, in the multivariable analysis, the transapical assess remained as an independent predictor of AKI, with an incremental risk between 4.7-fold and 5.2-fold. Similarly, Aregger et al. found a higher incidence of AKI in patients undergoing transapical TAVI (47% vs 8%; P = 0.003). It is of note that the transapical approach was used in only 12 patients -a very small number from which to draw a conclusion [16] .
Several investigators have shown a relatively higher incidence of AKI after TAVI that was related to the severe comorbidities of the patients. However, it is unclear which of these co-morbidities contribute most to deteriorated renal function after TAVI. Most of the studies reviewed performed univariate and multivariable Cox regressions to analyse such variables as risk factors for AKI after TAVI. Several studies found a correlation between AKI and baseline renal function [2, 6, 15] . For instance, the recently published study by Alassar et al. found a preoperative creatinine concentration > 104 mol/L to be a risk factor for AKI [11] . However, Sinning et al. found that a baseline creatinine concentration ≥ 1.58 mg/dL was a predictor for developing AKI (hazard ratio 3.9, 95% confidence interval 1.6-9.5; P = 0.002) [6] . In our previous study, baseline serum creatinine concentration remained the only predictor for AKI in the multivariable analysis (odds ratio 3.7, 95% confidence interval 1.24-11.3; P = 0.019) [2] .
Other studies have demonstrated that blood transfusion is a predictor of AKI [12, 13, 16, 17] . Preserved red blood cells undergo progressive functional and structural changes, leading to a deterioration in red blood cell function and viability, and accumulate free iron and pro-inflammatory agents; all of these changes may favour renal dysfunction, particularly, in patients with advanced age with peripheral vascular disease and diabetes mellitus [18, 19] . Bagur et al. showed that patients who had received red blood cells had a > three-fold increase in AKI occurrence [12] . Saia et al. found that 61.9% of the patients presented with AKI after TAVI received red Table 4 Predictors of acute kidney injury.
Study
Variable HR (95% CI)
Elhmidi et al. [2] Baseline creatinine 3.7 (1.24-11.3) Barbash et al. [14] Transapical access 2.9 (1.03-8.29) Sinning et al. [6] Baseline creatinine > 1.58 mg/dL 3.9 (1.6-9.5) Saia et al. [8] Transapical access 4.7 (1.6-13.89) Genereux et al. [9] Life-threatening bleeding 5.87 (1.84-14.76) adjusted Nuis et al. [13] Logistic [11] Baseline creatinine > 104 mol/L 1.04 Diabetes mellitus 6.7 [9] 44.4 55.6 6.4 NA Nuis et al. [13] 23 55 8 NA Van Linden et al. [10] 26.2 55 8.8 NA Strauch et al. [7] 25 NA NA NA Bagur et al. [12] 28 NA 9.8 NA Aregger et al. [16] 13.3 NA NA NA Khawaja et al. [15] 13.5 31.5 NA NA Gebauer et al. [25] 29 43 NA NA AKI: acute kidney injury; NA: not available.
blood cell transfusion intraoperatively compared with only 41.7% of the patients with no AKI (P = 0.04) [8] . In this latter study, red blood cells were not a predictor of AKI after TAVI. Similarly, in the study by Nuis et al., patients who developed AKI underwent significantly more red blood cell transfusion than those with no AKI (2.7 ± 3.6 units vs 1.1 ± 1.3 units; P = 0.001) [13, 17] . Some authors have suggested that severe hypotension, induced by ventricular rapid pacing, may lead to deterioration in renal perfusion and thereby, renal dysfunction, with an increased risk of AKI. Ventricular rapid pacing is a ''conditio sine qua non'' for aortic valvuloplasty, balloon-expandable valve deployment and post-implantation dilation. Interestingly, Bagur et al. found no correlation between the number of rapid pacing runs and the occurrence of AKI [12] .
Contrast agent and the risk of acute kidney injury
In previous studies, contrast agent volume > 100 mL was associated with higher contrast-induced nephropathy and mortality after coronary interventions [20] [21] [22] . The volume of contrast agent given during the implantation varied from 79 ± 55 mL to 242 ± 101 mL. The contrast agent was associated with AKI in only one study [10] ; patients with AKI had more contrast agent than those without AKI [10] . Moreover, patients undergoing RRT needed more contrast agent than those without RRT (139 ± 136 mL vs 93 ± 35 mL; P < 0.001). Contrast agent > 99 mL was an independent predictor of AKI. Similarly, Strauch et al. assumed an association between contrast agent and AKI [7] . Of note, the latter study included only 28 patients undergoing TAVI; the small number meant that Cox regression analysis was not possible. Differences in the relationship between the amount of contrast used in each study and the occurrence of AKI are noteworthy, as all TAVI procedures require contrast agent. One reason for this may be associated with the fact that patients with known renal failure or a higher preoperative serum creatinine concentration receive a smaller volume of contrast agent than patients without pre-existing renal failure.
Nonetheless, efforts to reduce the amount of contrast agent during implantation should be made. The use of echocardiographic or magnetic resonance imaging guidance in valve deployment [23, 24] may reduce the amount of contrast agent used in TAVI.
Acute kidney injury and mortality
In all studies, patients who developed AKI after TAVI exhibited a 2-6-fold higher mortality rate. The 30-day and 1-year mortality rates ranged from 8.8% to 44.4% and 31.5% to 55.5%, respectively. Moreover, mortality increased in those patients undergoing RRT of ≥ 10% (Table 5) .
All studies have shown AKI to be a powerful predictor of mortality at short-and long-term follow-up after TAVI [2, 6, [12] [13] [14] [15] . AKI was associated with a 4-fold higher mortality rate and this association persisted independent of baseline characteristics and periprocedural complications during TAVI [12] . One may suggest that AKI is a marker for multiorgan failure and is therefore associated with a higher mortality rate. Patients developing AKI subsequently had a systemic inflammatory response syndrome (60% vs 21%; P = 0.002), which may explain the pathophysiology of a higher leukocyte count and thrombocytopoenia, as stated in previous studies [6, 13] .
Improvement in renal function after TAVR
The reviewed studies assessed the occurrence of AKI and its impact on mortality. Nonetheless, a few reports showed an important improvement in renal function in patients following TAVI [2, 12] . Bagur et al. showed no changes in eGFR in 1% of the patients, 48 hours after TAVI, but a significant increase in eGFR in 60% of the patients [12] . Of note, AKI was defined according to the RIFLE criteria within 48 hours after the procedure. However, this 48-hour window is not adequate for assessing the occurrence of AKI, given that the creatinine concentration peak in patients with AKI is typically late (3-7 days) [2, 14] . Similarly, Saia et al. found that GFR increased in 58% of the patients and remained unchanged in 4% [8] . In accordance with these studies, we reported in our previous study an increase in eGFR in 59.6% of all the patients, while 3.5% showed no changes in eGFR [2] .
Conclusion
Acute kidney injury is a common complication, with an incidence of 8.3% to 57% in patients following TAVI. Patients developing AKI after TAVI exhibited a 2-6-fold higher mortality rate. A higher preoperative creatinine concentration, blood transfusion and peripheral vascular disease are independent predictors of AKI after TAVI.
